Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab maintenance versus no maintenance after rituximab-chemotherapy induction in advanced follicular lymphoma
2004-001756-36Phase 3Completed
- Sponsor
- Lymphoma Study Association
- Start
- Jan 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of rituximab in follicular lymphoma (FL) (2 arms), sponsored by Lymphoma Study Association. Primary endpoint: Progression-free survival. Started Jan 2005; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on 2004-001756-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001756-36.